Virtu Financial LLC Sells 10,377 Shares of Cardinal Health, Inc. (NYSE:CAH)

Virtu Financial LLC decreased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 50.4% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,195 shares of the company’s stock after selling 10,377 shares during the period. Virtu Financial LLC’s holdings in Cardinal Health were worth $1,127,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the business. Assenagon Asset Management S.A. grew its stake in Cardinal Health by 9.4% during the second quarter. Assenagon Asset Management S.A. now owns 10,385 shares of the company’s stock valued at $1,021,000 after acquiring an additional 891 shares in the last quarter. Blue Trust Inc. boosted its holdings in shares of Cardinal Health by 41.5% during the 2nd quarter. Blue Trust Inc. now owns 3,400 shares of the company’s stock valued at $334,000 after purchasing an additional 998 shares during the last quarter. Hennion & Walsh Asset Management Inc. grew its position in shares of Cardinal Health by 15.4% during the second quarter. Hennion & Walsh Asset Management Inc. now owns 18,694 shares of the company’s stock valued at $1,838,000 after purchasing an additional 2,488 shares in the last quarter. Milestone Asset Management LLC increased its holdings in shares of Cardinal Health by 7.7% in the second quarter. Milestone Asset Management LLC now owns 5,689 shares of the company’s stock worth $559,000 after purchasing an additional 408 shares during the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. increased its holdings in shares of Cardinal Health by 6.1% in the second quarter. Harel Insurance Investments & Financial Services Ltd. now owns 38,895 shares of the company’s stock worth $3,854,000 after purchasing an additional 2,225 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Up 0.5 %

Shares of NYSE:CAH opened at $118.06 on Friday. The company has a market capitalization of $28.57 billion, a price-to-earnings ratio of 22.97, a PEG ratio of 1.47 and a beta of 0.61. Cardinal Health, Inc. has a 12 month low of $93.17 and a 12 month high of $126.23. The firm’s 50-day moving average is $117.12 and its 200 day moving average is $108.35.

Cardinal Health (NYSE:CAH) last released its earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The firm had revenue of $52.28 billion for the quarter, compared to analysts’ expectations of $50.90 billion. During the same quarter in the prior year, the firm posted $1.73 earnings per share. The company’s quarterly revenue was down 4.3% on a year-over-year basis. As a group, equities analysts forecast that Cardinal Health, Inc. will post 7.82 EPS for the current fiscal year.

Cardinal Health Cuts Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be given a dividend of $0.5056 per share. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $2.02 annualized dividend and a dividend yield of 1.71%. Cardinal Health’s dividend payout ratio (DPR) is 39.30%.

Analysts Set New Price Targets

CAH has been the subject of several research analyst reports. Barclays raised their price target on Cardinal Health from $117.00 to $133.00 and gave the company an “overweight” rating in a report on Monday, November 4th. Argus increased their target price on Cardinal Health from $115.00 to $125.00 and gave the company a “buy” rating in a research report on Wednesday, September 11th. Mizuho started coverage on shares of Cardinal Health in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $139.00 price target on the stock. JPMorgan Chase & Co. increased their price objective on shares of Cardinal Health from $111.00 to $123.00 and gave the company a “neutral” rating in a research report on Wednesday, August 21st. Finally, Wells Fargo & Company raised shares of Cardinal Health from an “underweight” rating to an “equal weight” rating and lifted their price objective for the stock from $101.00 to $127.00 in a research note on Friday. Five equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $126.75.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.